(Q40692898)

22 September 2017

0 references

Pharmacoeconomic analysis of empirical therapy with ceftazidime alone or combination antibiotics for febrile neutropenia in cancer patients (English)

1 reference

22 September 2017

0 references

1 reference

1

G Dranitsaris

1 reference

22 September 2017

T M Tran

2

1 reference

22 September 2017

A McGeer

series ordinal

3

1 reference

22 September 2017

L Narine

series ordinal

4

1 reference

22 September 2017

language of work or name

1 reference

1 January 1995

1 reference

22 September 2017

1 reference

22 September 2017

7

1 reference

22 September 2017

49-62

1 reference

22 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-199507010-00006

22 September 2017

0 references

cites work

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

1 reference

12 December 2020

Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis

1 reference

12 December 2020

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

12 December 2020

Monotherapy for empiric treatment of fever in granulocytopenic cancer patients

1 reference

12 December 2020

Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

12 December 2020

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

12 December 2020

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

12 December 2020

Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients

1 reference

12 December 2020

A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin

1 reference

12 December 2020

Meta-analysis for combining Bayesian probabilities

1 reference

12 December 2020

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

1 reference

12 December 2020

Early results of a comparative trial of ceftazidime versus cephalothin, carbenicillin and gentamicin in the treatment of febrile granulocytopenic patients

1 reference

12 December 2020

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

12 December 2020

Meta-analyses of randomized controlled trials.

1 reference

12 December 2020

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

12 December 2020

10.2165/00019053-199507010-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

22 September 2017

0 references

1 reference